The Future of Precision Medicine: Potential Impacts for Health Technology Assessment.

PharmacoEconomics
James Love-KohMatthew Taylor

Abstract

Precision medicine allows healthcare interventions to be tailored to groups of patients based on their disease susceptibility, diagnostic or prognostic information, or treatment response. We analysed what developments are expected in precision medicine over the next decade and considered the implications for health technology assessment (HTA) agencies. We performed a pragmatic literature search to account for the large size and wide scope of the precision medicine literature. We refined and enriched these results with a series of expert interviews up to 1 h in length, including representatives from HTA agencies, research councils and researchers designed to cover a wide spectrum of precision medicine applications and research. We identified 31 relevant papers and interviewed 13 experts. We found that three types of precision medicine are expected to emerge in clinical practice: complex algorithms, digital health applications and 'omics'-based tests. These are expected to impact upon each stage of the HTA process, from scoping and modelling through to decision-making and review. The complex and uncertain treatment pathways associated with patient stratification and fast-paced technological innovation are central to these effects...Continue Reading

References

Mar 26, 1999·Health Affairs·R A Merrill
Oct 6, 2007·BMJ : British Medical Journal·Janice Hopkins Tanne
Jan 9, 2008·Journal of Health Economics·Werner B F BrouwerFrans F H Rutten
Mar 22, 2008·British Dental Journal·P GillB Chadwick
May 30, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Morris W FosterRichard R Sharp
Jun 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Laura BojkeStephen Palmer
May 6, 2010·European Journal of Human Genetics : EJHG·Heather SkirtonUNKNOWN Members of Eurogentest Unit 6 and ESHG Education Committee
Apr 1, 2011·International Journal of Technology Assessment in Health Care·Lidia BeclaAngela Brand
Nov 30, 2011·BMJ : British Medical Journal·Douglas NobleTrisha Greenhalgh
Apr 21, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Katrina A B GoddardDavid L Veenstra
Dec 19, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Eric FaulknerUNKNOWN Personalized Medicine Development and Reimbursement Working Group
Apr 2, 2013·Medical Decision Making : an International Journal of the Society for Medical Decision Making·David EpsteinMarta O Soares
Sep 27, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lieven AnnemansKatherine Payne
Sep 27, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Adrian Towse, Louis P Garrison
Oct 9, 2013·The Medical Journal of Australia·Jan R R LewisRichard O Day
Nov 19, 2013·Pharmacogenomics·James BuchananAnna Schuh
Mar 13, 2014·JAMA : the Journal of the American Medical Association·Frederick E DeweyThomas Quertermous
Mar 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarah K ByronAdrian Newland
May 9, 2014·International Journal of Technology Assessment in Health Care·Don HusereauJeffrey S Hoch
Jun 20, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Manuel A EspinozaMark J Sculpher
Dec 10, 2014·Journal of Clinical Pathology·Emad A RakhaUNKNOWN National Coordinating Committee for Breast Pathology
Feb 28, 2015·Genome Medicine·Ingrid SladeUNKNOWN MCG programme
May 1, 2015·JAMA : the Journal of the American Medical Association·Euan A Ashley
Aug 21, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Livio GarattiniNick Freemantle
Aug 27, 2015·Pharmacogenomics and Personalized Medicine·Fatiha H ShabaruddinKatherine Payne
Sep 27, 2015·Chinese Clinical Oncology·Richard Kaplan
Jan 24, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·E R Pearson
Jun 1, 2016·Frontiers in Pharmacology·Hans-Joerg FugelKen Redekop
Jul 19, 2016·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·Brett Doble
Aug 19, 2016·Journal of Epidemiology and Community Health·Tim Crocker-BuqueSandra Mounier-Jack
Aug 28, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Laura Vallejo-TorresPedro Serrano-Aguilar
Sep 7, 2016·Health Services & Outcomes Research Methodology·Demissie Alemayehu, Marc L Berger
Oct 27, 2016·JAMA : the Journal of the American Medical Association·Victor J Dzau, Geoffrey S Ginsburg
Oct 8, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Martine HoogendoornMaureen P M H Rutten-van Mölken
Nov 30, 2016·JAMA : the Journal of the American Medical Association·Saurabh Jha, Eric J Topol
Jan 27, 2017·Journal of Personalized Medicine·Miranta AntoniouAndrea L Jorgensen

❮ Previous
Next ❯

Citations

Jun 3, 2020·Fortschritte der Neurologie-Psychiatrie·Lara Stute, Rejko Krüger
Feb 13, 2020·F1000Research·Simon P Borg-BartoloRahul Kalla
Apr 23, 2020·Neuroradiology·Allard W OlthofMohammad H Rezazade Mehrizi
Jun 21, 2019·Gastroenterology Report·Susan FotheringhamDavid J Kerr
Apr 4, 2019·Applied Health Economics and Health Policy·Patrick FahrSarah Wordsworth
Dec 17, 2020·Journal of Personalized Medicine·Ines Viktoria StelzerJudit Simon
Apr 17, 2021·PharmacoEconomics·Heleen VellekoopUNKNOWN HEcoPerMed Consortium
Apr 30, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Martijn SimonsValesca Retèl
May 12, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Eric FaulknerKatherine Payne
May 20, 2021·Journal of Experimental & Clinical Cancer Research : CR·Xiang-Yuan LuoXing-Xing He
May 25, 2021·Applied Health Economics and Health Policy·Jennifer G GaultneyAndrew H Briggs
May 27, 2021·International Journal of Technology Assessment in Health Care·M Sazzad HussainGeremy Farr-Wharton
Jun 3, 2021·Journal of Personalized Medicine·Genevieve ShemieBartha Maria Knoppers
Jun 7, 2021·Journal of Translational Medicine·Dominik HartlAdrian Roth
Nov 19, 2021·Frontiers in Medicine·Laura Patricia Orellana GarcíaAngela Brand
Aug 31, 2021·The Canadian Journal of Cardiology·Dominique VervoortHarindra C Wijeysundera

❮ Previous
Next ❯

Software Mentioned

MAGIC
Sleepio
MyHeart
Excel
QRISK
Sapientia

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Bulletin of the World Health Organization
Hildy Fong, Eva Harris
International Journal of Technology Assessment in Health Care
Chris HenshallHTAi Policy Forum
International Journal of Technology Assessment in Health Care
Joost de FolterSarah Garner
Epidemiologia e prevenzione
Maria Lucia SpecchiaHTA Working Group of the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI)
© 2022 Meta ULC. All rights reserved